NO

North Carolina Pharmaceutical Services, LLC

  • CIK: 0001311395
  • EIN: 27-0041830
  • Business address: C/O US ONCOLOGY, INC., 16825 NORTHCHASE DRIVE, SUITE 1300, HOUSTON, Texas, 77060

Information

  • Mailing address
    C/O US ONCOLOGY, INC., 16825 NORTHCHASE DRIVE, SUITE 1300, HOUSTON, Delaware, 77060
  • Phone
    832-601-8766
  • State location
    Texas
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    8093 - (CF Office: Office of Life Sciences) SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC
  • Filings
    N/A

About North Carolina Pharmaceutical Services, LLC

North Carolina Pharmaceutical Services, LLC (CIK: 0001311395) is an American company incorporated in the state of Texas. Head office is located at C/O US ONCOLOGY, INC., 16825 NORTHCHASE DRIVE, SUITE 1300, HOUSTON, Texas, 77060. Work in the industry 8093 - (CF Office: Office of Life Sciences) SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC. North Carolina Pharmaceutical Services, LLC is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by North Carolina Pharmaceutical Services, LLC

Filings Format Description Filed/Effective File/Film Number
EFFECT Document Acc-no: 9999999995-10-000134 (33 Act) Size: 30 KB Jan-07-2010

333-162514-22

10515998
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001193125-09-259422 (33 Act) Size: 5675 KB		 Dec-23-2009

333-162514-22

091258894
UPLOAD Document Acc-no: 0000000000-09-069989 ( Act) Size: 56 KB Dec-11-2009

AW Document

Withdrawal of amendment to a registration statement filed under the Securities Act

Acc-no: 0001193125-09-249216 (NE Act) Size: 27 KB		 Dec-08-2009

333-162514-22

091228611
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001193125-09-248624 (33 Act) Size: 477 KB		 Dec-08-2009

333-162514-22

091227112
S-4/A Document

Amendment to Registration of securities issued in business combination transactions

Acc-no: 0001193125-09-248515 (33 Act) Size: 477 KB		 Dec-07-2009

333-162514-22

091226620
EFFECT Document Acc-no: 9999999995-09-003027 (33 Act) Size: 30 KB Nov-03-2009

333-162514-22

091156146
S-4/A Document

Amendment to Registration of securities issued in business combination transactions

Acc-no: 0001193125-09-213715 (33 Act) Size: 5725 KB		 Oct-26-2009

333-162514-22

091136783
S-4 Document

Registration of securities issued in business combination transactions

Acc-no: 0001193125-09-208587 (33 Act) Size: 10104 KB		 Oct-15-2009

333-162514-22

091122038
424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0001047469-05-006794 (33 Act) Size: 1771 KB		 Mar-16-2005

333-121410-14

05686179
S-4/A Document

Amendment to Registration of securities issued in business combination transactions

Acc-no: 0001047469-05-006677 (33 Act) Size: 2009 KB		 Mar-16-2005

333-121410-14

05684168
S-4/A Document

Amendment to Registration of securities issued in business combination transactions

Acc-no: 0001047469-05-006294 (33 Act) Size: 2025 KB		 Mar-14-2005

333-121410-14

05677103
S-4 Document

Registration of securities issued in business combination transactions

Acc-no: 0001047469-04-037612 (33 Act) Size: 11648 KB		 Dec-17-2004

333-121410-14

041211856

Recent 20 filings. View all North Carolina Pharmaceutical Services, LLC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • North Carolina Pharmaceutical Services, LLC overview
  • North Carolina Pharmaceutical Services, LLC job
  • North Carolina Pharmaceutical Services, LLC stock
  • North Carolina Pharmaceutical Services, LLC ownership
  • North Carolina Pharmaceutical Services, LLC CEO
  • North Carolina Pharmaceutical Services, LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Concentra Group Holdings Parent, Inc.
Update: Jun 15, 2024
Washington Pharmaceutical Services, LLC
Update: Aug 25, 2022
VISTA LASER CENTERS OF MICHIGAN INC
Update: Aug 24, 2022
VAKOUTIS JOHN
Update: Aug 24, 2022
US Oncology Pharmaceutical Services, LLC
Update: Aug 24, 2022
UCI MEDICAL AFFILIATES INC
Update: Aug 24, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2659 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3817 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1137 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2946 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 3482 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2641 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 3589 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 2762 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 1344 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by